Misconduct In Research: An Ethical Problem For All

Scientific misconduct, to most scientists, is an ethical issue in academic life. It is rapidly becoming a legal issue as well, which was underscored by the convening of a recent conference on the issue. The conference, entitled "Misconduct in Science--Recurring Issues, Fresh Perspectives," was held in Cambridge, Mass., on Nov. 15 and 16, 1991. The average scientist now has cause to worry. At the conference, Jules Hallum, director of the National Institutes of Health's Office of Scientific Inte

Written byKenneth Foster
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The average scientist now has cause to worry. At the conference, Jules Hallum, director of the National Institutes of Health's Office of Scientific Integrity (OSI), summarized the activities of his organization, which investigates cases of alleged scientific misconduct in NIH-funded research. At its start in 1989, OSI had 70 cases; it has since resolved 110 cases and now faces a backlog of 70 more. Other agencies have their own staffs to handle such cases. Scientific misconduct, as defined by NIH, includes falsification of data or plagiarism--as well as practices that "seriously deviate from those that are commonly accepted" by the scientific community. (The National Science Foundation has a similar definition.) Scientific misconduct is an offense with no statute of limitations and no significant body of case law to serve as precedent.

Surely, egregious falsification or plagiarism is an outrage that should be punished. But as Eleanor Shore, dean for faculty ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies